Correction to “Triply Enhanced Immunotherapy via Dual Glycan Reforming Integrated with Perforation”
Yuanjiao Yang, Yuru Wang, Zhicong Chao, Yuhui Yang, Yanyun Fang, Ying Liu, Lin Ding, Yunlong Chen, Huangxian Ju

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmunotherapy and Immune Responses · Glycosylation and Glycoproteins Research · Biopolymer Synthesis and Applications
Adv. Sci. 2023, 2304971
https://doi.org/10.1002/advs.202304971
Pages 3, 6 and 7. We noticed misuses of the CLSM images in Figure 2b line 3 for SLO‐Gal and Figure 4f lines 1 and 4 for Control and SLO‐Gal&SLO‐NEU, respectively, and the H&E staining image in Figure 5e line 1 column 4 for SLO@HA.
Pages 7 and 12 in Supporting Information. There are misuses of the CLSM images in Figure S3c lines 2 and 3 for GD and GD+SLO, respectively, and the H&E staining images in Figure S14 line 1 columns 4, 6 and 7 for SLO@HA, SLO‐NEU@HA and TEID respectively, line 2 column 7 for TEID, line 3 column 7 for TEID, line 4 columns 6 and 7 for SLO‐NEU@HA and TEID respectively, and line 5 column 4 for SLO@HA.
These images need to be corrected, but the results and conclusions in the published Article are not changed. The corrected Figures 2, 4 and 5 are presented below. Figures S3 and S14 have been corrected in the updated Supporting Information.
Supporting information
Supporting Information
